Autologous Matrix-induced Chondrogenesis Market New Era Of Industry and Forecast -2031Posted by Aparna P on August 29th, 2022  Autologous matrix-induced chondrogenesis is a new type of treatment method for repairing articular cartilage damage. It is a single step procedure that makes use of microfracturing method. This step is then followed by applying a layer of bilayer collagen I/II membrane. This membrane is applied with the help of partially autologous fibrin glue.
Some of the leading companies in the global autologous matrix-induced chondrogenesis market include names such as Zimmer Biomet Holdings, Geistlich Pharma AG, Matricel GmbH, Melsungen AG, B Barun AG, JRL Orthopedic Ltd., ArthroKinetics, and Biotissue AG among others.
DOWNLOAD A BROCHURE OF THE LATEST RESEARCH REPORT
The global autologous matrix-induced chondrogenesis market has five major regional segments that divide it in terms of geography. These regions are North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Currently, the autologous matrix-induced chondrogenesis market is globally dominated by the regional segment of North America.
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Like it? Share it! More by this author |